Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print June 26, 2007
DOI: 10.2337/dc07-0637

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0637v1
30/9/2362    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muscari, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muscari, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count and erythrocyte sedimentation rate. A comparison study in an elderly population

Antonio Muscari, MD, Serafina Antonelli, MD*, Giampaolo Bianchi, MD, Giulia Cavrini, PhD{dagger}, Susanna Dapporto, MD, Amedeo Ligabue, MD*, Cosimo Ludovico, MD, Donatella Magalotti, MD, Guido Poggiopollini, MD, Marco Zoli, MD on behalf of the Pianoro Study Group

Internal Medicine, Cardioangiology, Hepatology, University of Bologna,
*Laboratory of the Azienda USL Bologna, and
{dagger} Statistical Sciences, University of Bologna, Bologna, Italy

amuscari{at}med.unibo.it

ABSTRACT

Objective.: This study was performed to ascertain the relative relevance of some inflammatory markers in insulin resistance.

Research Design and Methods.: Four inflammatory markers (leukocyte count, erythrocyte sedimentation rate (ESR), high sensitivity C-reactive protein (CRP) and C3 complement) were assessed as possible determinants of the HOMA (homeostasis model assessment) index, together with the 5 elements of the metabolic syndrome (NCEP-ATPIII definition), total cholesterol, physical activity and 4 indicators of adiposity (body mass index, waist circumference, %body fat and hepatic steatosis) in an unselected population of 990 subjects aged 65-91 years (the Pianoro Study).

Results.: In univariable analysis C3, CRP and leukocyte count, but not ESR, were significantly correlated with HOMA index. In multivariable analysis C3 remained associated with insulin resistance with the highest partial-R2 value (0.049), independently of all other covariates. The other most significant (P<0.0001) determinants of HOMA index were total cholesterol (inverse association, partial-R2=0.026), waist circumference (partial-R2=0.023), triglycerides (partial-R2=0.022) and hepatic steatosis (partial-R2=0.021) (R2=0.450 for the whole model).

The adjusted relative risks of having the metabolic syndrome for the subjects with inflammatory markers in the high tertile, with respect to those with lower values, were (prevalence ratio, 95 % CI): 1.77, 1.41-2.22 for C3; 1.38, 1.12-1.70 for leukocyte count; 1.17, 0.94-1.46 for CRP; and 1.13, 0.91-1.40 for ESR.

Conclusions.: Of the 4 inflammatory markers simultaneously assessed in our elderly population, only C3 was strongly associated with insulin resistance, independently of the components of the metabolic syndrome and the main indices of abdominal and general obesity.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Paglialunga, A. Fisette, Y. Yan, Y. Deshaies, J.-F. Brouillette, M. Pekna, and K. Cianflone
Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice
Am J Physiol Endocrinol Metab, March 1, 2008; 294(3): E521 - E529.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.